Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Factor II G20210A and factor V G1691A gene mutations and peripheral arterial occlusive disease.

Thrombosis and haemostasis - 1 Jan 2000

Renner W, Köppel H, Brodmann M, Pabst E, Schallmoser K, Toplak H, Wascher T C, Pilger E

Abstract excerpt

BACKGROUND: G to A mutations at positions 20210 of the prothrombin gene (F2) and 1691 of the factor V gene (F5) are established risk factors for venous thrombosis. Several factors associated with coagulation and/or fibrinolysis have been associated with arterial occlusive disease, but the role of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Factor V
Share to Mutation
Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Arterial Occlusive Diseases

Share to Prothrombin

Share to Risk Factors

Source

Identifiers

PMID: 10669148

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-10669148-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Factor II G20210A and factor V G1691A gene mutations and peripheral arterial occlusive disease.PMID 10669148Read ↗

Prothrombin G20210A, factor V Leiden, and factor XIII Val34Leu: common mutations of blood coagulation factors and deep vein thrombosis in Austria.Semantic proximity Read ↗

The prothrombin 20210 G to A variation and thrombosis.Semantic proximity Read ↗

Prevalence of genetic prothrombotic risk factors: 1691G > A FV, 20210G > A PT and 677C > T MTHFR mutations in the Bosnian population.Semantic proximity Read ↗

The prothrombin gene variant 20210A in venous and arterial thromboembolism.Semantic proximity Read ↗

Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.Semantic proximity Read ↗

Prevalence of the prothrombin gene variant (nt20210A) in venous thrombosis and arterial disease.Semantic proximity Read ↗

The prevalence of factor V (G1691A), MTHFR (C677T) and PT (G20210A) gene mutations in arterial thrombosis.Semantic proximity Read ↗

Homozygotes for prothrombin gene 20210 A allele in a thrombophilic family without clinical manifestations of venous thromboembolism.Semantic proximity Read ↗

Clinical and Molecular Study of Common Thrombophilia Mutation Prothrombin G20210A.Semantic proximity Read ↗

The 20210 A allele of the prothrombin gene is a common risk factor among Swedish outpatients with verified deep venous thrombosis.Semantic proximity Read ↗

Coinheritance of factor V Leiden (F5 1691A) and prothrombin 20210 A (F2 20210A) in an Austrian family as cause for early onset of venous thromboembolism.Semantic proximity Read ↗

Venous thrombosis with both heterozygous factor V Leiden (R507Q) and factor II (G20210A) mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.